Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma?

  title={Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma?},
  author={B. Challis and R. Casey and H. Simpson and M. Gurnell},
  journal={Clinical Endocrinology},
  • B. Challis, R. Casey, +1 author M. Gurnell
  • Published 2017
  • Medicine
  • Clinical Endocrinology
  • Phaeochromocytomas and paragangliomas (PPGLs) are catecholamine secreting neuroendocrine tumours that predispose to haemodynamic instability. Currently, surgery is the only available curative treatment, but carries potential risks including hypertensive and hypotensive crises, cardiac arrhythmias, myocardial infarction and stroke, due to tumoral release of catecholamines during anaesthetic induction and tumour manipulation. The mortality associated with surgical resection of PPGL has… CONTINUE READING
    15 Citations
    The use of doxazosin before adrenalectomy for pheochromocytoma: is the duration related to intraoperative hemodynamics and postoperative complications?
    • PDF
    Effects of pretreatment with terazosin and valsartan on intraoperative haemodynamics in patients with phaeochromocytoma


    Perioperative management of phaeochromocytoma.
    • 29
    Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection.
    • 66
    The impact of changes in drug availability for hemodynamic management in pheochromocytoma: prêt-à-porter or tailor-made?
    • M. James
    • Medicine
    • Canadian Journal of Anesthesia/Journal canadien d'anesthésie
    • 2015
    • 11
    • PDF
    Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary?
    • 50
    Management and Treatment of Pheochromocytomas and Paragangliomas
    • M. Mannelli
    • Medicine
    • Annals of the New York Academy of Sciences
    • 2006
    • 73
    The Preoperative Management of Phaeochromocytoma
    • 62
    Surgical management of pheochromocytoma with the use of metyrosine.
    • 69